CITADEL ADVISORS LLC 13D and 13G filings for Protagonist Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:58 pm Sale | 2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | CITADEL ADVISORS LLC | 390,512 0.700% | -2,292,302 (-85.44%) | Filing |
| 2023-01-03 4:22 pm Purchase | 2022-12-21 | 13G | Protagonist Therapeutics, Inc. PTGX | CITADEL ADVISORS LLC | 2,682,814 5.500% | 2,682,814 (New Position) | Filing |